We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics- Hematology Division

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Easy-To-Use Breath Test Uses AI Algorithm to Accurately Detect COVID-19 in Less Than One Minute

By LabMedica International staff writers
Posted on 21 Jun 2021
Print article
Image: The BreFence Go COVID-19 breath test system (Photo courtesy of Breathonix Pte Ltd)
Image: The BreFence Go COVID-19 breath test system (Photo courtesy of Breathonix Pte Ltd)
A new COVID-19 breath test system detects volatile organic compounds (VOCs) in a person’s exhaled breath to generate results within one minute

The BreFence Go COVID-19 breath test system developed by Breathonix Pte Ltd (Singapore) has received provisional approval from Singapore’s Health Sciences Authority (HSA), and is the first breath analysis system to secure such authorization in Singapore. The BreFence Go COVID-19 breath test system works by detecting VOCs in a person’s exhaled breath that are produced by biochemical reactions in human cells. VOC signatures in the breath of healthy people vary from that of people with illnesses, meaning that changes in VOCs can be measured as markers for diseases like COVID-19.

Individuals screened as positive by the breath test will have to undergo a confirmatory polymerase chain reaction (PCR) COVID-19 swab test. The system was developed from Breathonix’s cancer detection technology. The breath test system underwent clinical trials at the National Centre for Infectious Diseases (NCID) and Changi Airport, as well as in Dubai.

“The breath test is simple to administer by trained personnel but does not require medically trained staff or laboratory processing,” NUS and Breathonix said in a media release. “A person only needs to blow into a disposable one-way valve mouthpiece connected to a high-precision breath sampler. The exhaled breath is collected and fed into a cutting-edge mass spectrometer for measurement. A proprietary software algorithm analyses the VOCs biomarkers and generates results in less than a minute.”

“Our breath test is non-invasive,” said Dr. Jia Zhunan, CEO of Breathonix. “Users only need to breathe out normally into the disposable mouthpiece provided, so there will not be any discomfort. Cross-contamination is unlikely as the disposable mouthpiece has a one-way valve and a saliva trap to prevent inhalation or saliva from entering the machine.”

Related Links:
Breathonix Pte Ltd

Gold Supplier
SARS-CoV-2 Antibody Test
SARS-CoV-2 UTAB FS
New
Cooling System
Cryolys Evolution
New
Glucose & Lactate Measurement Analyzer
ecoTwenty
New
Quantitative SARS-CoV-2 Neutralizing Antibody ELISA
KTR-1036 EDI Quantitative SARS-CoV-2 Neutralizing Antibody ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Primary angle closure glaucoma can cause permanent blindness if not treated quickly. A highly sensitive genetic test has been developed (Photo courtesy of Flinders University)

Highly Sensitive Genetic Test for Glaucoma Developed

In open-angle glaucoma, the angle in the eye where the iris meets the cornea is as wide and open as it should be, but the eye’s drainage canals become clogged over time, causing an increase in internal... Read more

Industry

view channel
Illustration

ELITechGroup Acquires Freezing Point Osmometry Provider GONOTEC

ELITechGroup (Puteaux, France) has acquired GONOTEC (Berlin, Germany), thus uniting two osmometry market leaders. The acquisition will also provides the industry with a full range of osmometry solutions... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.